Novartis | Revenu Net



Net Income Changement Date
AbbVie USD -22000000 1.58B 2024-12
Amgen USD 627M 2.2B 2024-12
AstraZeneca USD 1.5B 71M 2024-12
Bausch Health Companies USD -85000000 95M 2024-09
Biogen USD 266.7M 121.8M 2024-12
Bristol-Myers Squibb USD 72M 1.14B 2024-12
Canopy Growth CAD -121896000 6.4M 2024-12
Corcept Therapeutics USD 30.75M 16.47M 2024-12
Drreddys Laboratories INR 14.13B 1.58B 2024-12
Eli Lilly USD 4.41B 3.44B 2024-12
Gilead Sciences USD 1.78B 529M 2024-12
GlaxoSmithKline GBP 414M 472M 2024-12
Glaxosmithkline GBP 414M 472M 2024-12
Indivior 4M 111M 2024-09
J&J USD 3.43B 737M 2024-12
Merck USD 3.74B 586M 2024-12
Novartis USD 2.82B 371M 2024-12
Novartis USD 2.82B 371M 2024-12
Pacira USD 16.04M 159.51M 2024-12
Perrigo USD -44500000 23.5M 2024-12
Pfizer USD 410M 4.06B 2024-12
Prestige Brands USD 61.03M 6.65M 2024-12
Roche Holding CHF 1.01B 2.12B 2024-12
Sanofi EUR 2.82B 1.7B 2024-09
Sanofi EUR 2.82B 1.7B 2024-09
Supernus Pharmaceuticals USD 15.33M 23.17M 2024-12
Zoetis USD 581M 101M 2024-12



Novartis Revenu Net - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2025.